Circuit Therapeutics

UEI: KSQ7UEY9J8K1 • CAGE: 6PNK5

Overview

Awardee Type

Parent

Federal Capability Statement

Alkahest is developing therapies derived from blood and its components with a focus to improve vitality and function into old age. We are working on treatments for diseases of aging, with an emphasis on cognitive dysfunction and dementia, which are key medical challenges of our generation.The Company is conducting clinical studies in patients with different types of dementia and other neurodegenerative diseases. Alkahest is a private company based in San Carlos, CA, with investors including Barcelona, Spain-based Grifols, a global healthcare company and leading producer of plasma therapies, also a collaboration and commercialization partner. For more information, please visit our website at http://www.alkahest.com.

Keywords

The aging process, The role of blood factors

Website

https://www.circuittx.com

Headquarters

Reno, NV
United States

Most Recent Award

March 31, 2020

Calculating

Federal contract recipient CIRCUIT THERAPEUTICS, INC. (UEI KSQ7UEY9J8K1, CAGE 6PNK5) is headquartered in Reno NV. Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). The corporation was founded in September 2010 and federally registered in March 2012.

Federal Award Analysis